Tower Research Capital LLC (TRC) - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 109 filers reported holding VIKING THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$89,346
+95.2%
8,071
+185.9%
0.00%
+50.0%
Q2 2023$45,761
+21085.6%
2,823
-78.2%
0.00%
-71.4%
Q1 2023$216
+535.3%
12,973
+262.2%
0.01%
+600.0%
Q4 2022$34
-98.3%
3,582
+452.8%
0.00%
Q3 2022$2,000648
+16100.0%
0.00%
Q2 2022$0
-100.0%
4
-100.0%
0.00%
-100.0%
Q1 2022$83,000
-69.8%
27,753
-53.6%
0.00%
-80.0%
Q4 2021$275,000
+192.6%
59,754
+303.0%
0.01%
+150.0%
Q3 2021$94,000
+235.7%
14,828
+217.0%
0.00%
+100.0%
Q2 2021$28,000
-34.9%
4,678
-31.5%
0.00%0.0%
Q1 2021$43,000
-29.5%
6,826
-37.6%
0.00%
-50.0%
Q4 2020$61,000
+1.7%
10,932
+6.7%
0.00%
+100.0%
Q3 2020$60,000
-59.5%
10,248
-49.9%
0.00%
-83.3%
Q2 2020$148,00020,468
+20368.0%
0.01%
Q1 2020$0
-100.0%
100
-96.9%
0.00%
-100.0%
Q4 2019$26,000
-52.7%
3,211
-59.9%
0.00%
-50.0%
Q3 2019$55,000
+2650.0%
8,001
+3261.8%
0.00%
Q2 2019$2,000238
+2875.0%
0.00%
Q4 2018$0
-100.0%
8
-98.5%
0.00%
Q3 2016$1,0000.0%528
-27.5%
0.00%
Q2 2016$1,0000.0%728
-25.5%
0.00%
Q1 2016$1,000
-90.9%
977
-48.7%
0.00%
-100.0%
Q3 2015$11,000
+450.0%
1,903
+521.9%
0.00%
Q2 2015$2,0003060.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders